Company profile · free preview

Becton, Dickinson and Company

BDX · NYSE · Healthcare · Updated 11/14/2026

Revenue

$21.8B

Fiscal 2025

Net income

$1.7B

Fiscal 2025

Free cash flow

—

Fiscal 2025

Net cash / (debt)

—

Fiscal 2025

Five-year financials

Fiscal year20252024202320222021
Revenue$21.8B$20.2B$19.4B$18.9B$20.2B
Net income$1.7B$1.7B$1.5B$1.8B$2.1B
Diluted EPS—————
Operating cash flow————$4.6B
Free cash flow————$3.4B
Cash$641.0M$1.7B$1.4B$1.0B$2.3B
Total debt—————

Financial trends

Historical · FY2021–FY2025

Source: Reported annual filings (10-K / 20-F) and provider data. Fiscal years as reported; margins are calculated from the reported figures shown.

Want the story behind these numbers? Ask Osiris anything about Becton, Dickinson and Company's filings — free.

Create free account

Becton, Dickinson and Company return on capital (fiscal 2025)

ROIC

5.1%

Return on capital

4.9%

Return on equity

6.5%

Return on assets

3.0%

Gross margin

45.4%

Operating margin

13.7%

Net debt / EBITDA

3.68x

Becton, Dickinson and Company insider buying and selling

Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.

DateInsiderTypeSharesPrice
2026-11-05Polen Thomas E JrSale2,993$210.00
2026-10-26Feld MichaelSale76$198.13
2026-09-28Feld MichaelSale76$183.70
2026-08-26Feld MichaelSale165$188.49

SEC filings

No filings stored yet.

Ask anything about Becton, Dickinson and Company's filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

Compare BDX head-to-head

More Healthcare companies